Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

AEONREGN

AEON Biopharma, Inc.

AEON · $0.24

32Weak

Regeneron Pharmaceuticals, Inc.

REGN · $782.04

73Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

AEON

32/100

REGN

73/100

Quality

Is it a profitable, well-run business?

AEON

6.0/10

REGN

6.2/10

Growth

Is the company growing?

AEON

0.0/10

REGN

4.5/10

Valuation

Is the price reasonable? (higher = cheaper)

AEON

3.3/10

REGN

6.9/10

Risk

How risky are the shares? (higher = lower risk)

AEON

4.8/10

REGN

8.1/10

Momentum

Is the share price trending up?

AEON

2.9/10

REGN

8.4/10

Financial strength

Is the balance sheet healthy?

AEON

2.5/10

REGN

9.7/10

The balanced view

Model-generated

AEON Biopharma, Inc.

This company scores below average, with supportive analyst views, although its growth has been slow.

Leads on: no single area

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: growth is slow or negative (Net income growth (FY): -193.4%)

Regeneron Pharmaceuticals, Inc.

This company scores above average, with a healthy balance sheet and a positive price trend.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: healthy balance sheet (Altman Z-Score: 7.29)

Watch out: weakest area: growth potential (Revenue growth (FY): 1.0%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.